Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917787 · ClinicalTrials.gov registry record
Analysis of Blood-based Biomarkers of Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 127
- Enrollment target
NCT00917787: Completed study, sponsored by University of California, San Francisco.
NCT00917787 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00917787 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The purpose of this study is to analyze markers of inflammation in blood and in induced sputum for the purpose of identifying molecular markers of specific asthma phenotypes. The investigators' specific interest is demonstrating that periostin levels are higher than normal in blood. The investigators already have solid preliminary data to support this hypothesis, and our goal here is to replicate preliminary findings and extend them by examining further the characteristics of the asthma subgroup with elevated periostin levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-04 |
What the finished NCT00917787 record still lists
NCT00917787 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00917787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00917787 about?
NCT00917787 is a clinical study titled "Analysis of Blood-based Biomarkers of Asthma". The purpose of this study is to analyze markers of inflammation in blood and in induced sputum for the purpose of identifying molecular markers of specific asthma phenotypes. The investigators' specific interest is demonstrating that periostin levels are higher than normal in blood. The investigator...
What is the current status of trial NCT00917787?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2009-06. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00917787?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia